bpc-157 benefits risks clinical studies What Science ACTUALLY Says About BPC 157 Peptide Therapy for Inflammation: A
Description
These shorter peptide fragments aim to reproduce specific structural features of the BDNF-TrkB binding interface
[DOI] [PubMed] [Google Scholar] 116
In future work, the researchers hope to continue developing the plant-growing IGF-1 to move it to the clinic, not only for bone fracture healing but for other musculoskeletal problems as well, including osteoporosis and bone regeneration following cancer
BPC 157 counteracts the VEGF tumor-promoting effect and inhibits cell growth and VEGF signaling via the MAPK kinase pathway in the human melanoma cell line [95]
Armando T
PMID 22254022
